Risk factors of organ failure in patients with bacteremic cholangitis

Digestive Diseases and Sciences

Volumn 58, Issue 4, 2013, Pages 1091-1099

  Lee, Ban Seok ^a,b,c   Hwang, Jin Hyeok ^a,b   Lee, Sang Hyub ^a,b   Jang, Sang Eon ^a,b   Jang, Eun Sun ^a,b   Jo, Hyun Jin ^a,b   Shin, Cheol Min ^a,b   Park, Young Soo ^a,b   Kim, Jin Wook ^a,b   Jung, Sook Hyang ^a,b   Kim, Nayoung ^a,b   Lee, Dong Ho ^a,b   Lee, Jun Kyu ^d   Ahn, Soyeon ^b  

^a Seoul National University   (South Korea)

^b Seoul National University Bundang Hospital   (South Korea)

^c Cheju Halla General Hospital   (South Korea)

^d Dongguk University Ilsan Hospital   (South Korea)

Author keywords

Bacteremia; Cholangitis; Multiple organ failure; Sepsis; Septic shock

Indexed keywords

BILIRUBIN; NITROGEN; UREA;

ADULT; AGED; ARTICLE; BACTEREMIA; BACTEREMIC CHOLANGITIS; BILIARY TRACT DRAINAGE; BILIRUBIN BLOOD LEVEL; CHOLANGITIS; DATA ANALYSIS; DEATH; DECOMPRESSION SURGERY; DISEASE ASSOCIATION; EXTENDED SPECTRUM BETA LACTAMASE PRODUCING ENTEROBACTERIACEAE; FEMALE; HOSPITAL ADMISSION; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; MULTIPLE ORGAN FAILURE; ORGAN DYSFUNCTION SCORE; PREDICTOR VARIABLE; PRIORITY JOURNAL; PROGNOSIS; RISK FACTOR; SCORING SYSTEM; SENSITIVITY AND SPECIFICITY; SURGICAL PATIENT; UREA NITROGEN BLOOD LEVEL;

AGED; AGED, 80 AND OVER; BACTEREMIA; CHOLANGITIS; DECOMPRESSION, SURGICAL; FEMALE; HUMANS; MALE; MIDDLE AGED; ORGAN DYSFUNCTION SCORES; RETROSPECTIVE STUDIES; RISK FACTORS;

EID: 84876668533     PISSN: 01632116     EISSN: 15732568     Source Type: Journal    
DOI: 10.1007/s10620-012-2478-8     Document Type: Article

References (44)

1. Yusoff IF, Barkun JS, Barkun AN. Diagnosis and management of cholecystitis and cholangitis. Gastroenterol Clin N Am. 2003;32:1145-1168.
2. Saik RP, Greenburg AG, Farris JM, Peskin GW. Spectrum of cholangitis. Am J Surg. 1975;130:143-150.
3. Rogers L. Biliary abscess of the liver with operation. Br Med J. 1903;2:706-707.
4. Bornman PC, van Beljon JI, Krige JE. Management of cholangitis. J Hepatobiliary Pancreat Surg. 2003;10:406-414.
5. Lee CC, Chang IJ, Lai YC, Chen SY, Chen SC. Epidemiology and prognostic determinants of patients with bacteremic cholecystitis or cholangitis. Am J Gastroenterol. 2007;102:563-569.
6. Kang CI, Song JH, Chung DR, et al. Risk factors and pathogenic significance of severe sepsis and septic shock in 2286 patients with gram-negative bacteremia. J Infect. 2011;62:26-33.
7. Rello J, Ricart M, Mirelis B, et al. Nosocomial bacteremia in a medical-surgical intensive care unit: epidemiologic characteristics and factors influencing mortality in 111 episodes. Intensive Care Med. 1994;20:94-98.
8. Pittet D, Thievent B, Wenzel RP, Li N, Gurman G, Suter PM. Importance of pre-existing co-morbidities for prognosis of septicemia in critically ill patients. Intensive Care Med. 1993;19:265-272.
9. Vincent JL, de Mendonca A, Cantraine F, et al. Use of the SOFA score to assess the incidence of organ dysfunction/failure in intensive care units: results of a multicenter, prospective study. Working group on "sepsis-related problems" of the European Society of Intensive Care Medicine. Crit Care Med. 1998;26:1793-1800.
10. Ziegler EJ, Fisher CJ Jr, Sprung CL, et al. Treatment of gram-negative bacteremia and septic shock with HA-1A human monoclonal antibody against endotoxin. A randomized, double-blind, placebo-controlled trial. The HA-1A Sepsis Study Group. N Engl J Med. 1991;324:429-436.
11. Brun-Buisson C, Doyon F, Carlet J. Bacteremia and severe sepsis in adults: a multicenter prospective survey in ICUs and wards of 24 hospitals. French Bacteremia-Sepsis Study Group. Am J Respir Crit Care Med. 1996;154:617-624.
12. Melzer M, Toner R, Lacey S, Bettany E, Rait G. Biliary tract infection and bacteraemia: presentation, structural abnormalities, causative organisms and clinical outcomes. Postgrad Med J. 2007;83:773-776.
13. Yokoe M, Takada T, Mayumi T, et al. Accuracy of the Tokyo guidelines for the diagnosis of acute cholangitis and cholecystitis taking into consideration the clinical practice pattern in Japan. J Hepatobiliary Pancreat Sci. 2011;18:250-257.
14. Bone RC, Balk RA, Cerra FB, et al. Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. The ACCP/SCCM Consensus Conference Committee. American College of Chest Physicians/Society of Critical Care Medicine. Chest. 1992;101:1644-1655.
15. Bone RC, Fisher CJ Jr, Clemmer TP, Slotman GJ, Metz CA, Balk RA. A controlled clinical trial of high-dose methylprednisolone in the treatment of severe sepsis and septic shock. N Engl J Med. 1987;317:653-658.
16. Nash K, Hafeez A, Hou S. Hospital-acquired renal insufficiency. Am J Kidney Dis. 2002;39:930-936.
17. Hou SH, Bushinsky DA, Wish JB, Cohen JJ, Harrington JT. Hospital-acquired renal insufficiency: a prospective study. Am J Med. 1983;74:243-248.
18. Murray SB, Bates DW, Ngo L, Ufberg JW, Shapiro NI. Charlson Index is associated with one-year mortality in emergency department patients with suspected infection. Acad Emerg Med. 2006;13:530-536.
19. Charlson ME, Pompei P, Ales KL, MacKenzie CR. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis. 1987;40:373-383.
20. Lau JY, Chung SC, Leung JW, Ling TK, Yung MY, Li AK. Endoscopic drainage aborts endotoxaemia in acute cholangitis. Br J Surg. 1996;83:181-184.
21. Pinsky MR, Vincent JL, Deviere J, Alegre M, Kahn RJ, Dupont E. Serum cytokine levels in human septic shock. Relation to multiple-system organ failure and mortality. Chest. 1993;103:565-575.
22. Akiyama T, Hasegawa T, Sejima T, et al. Serum and bile interleukin 6 after percutaneous transhepatic cholangio-drainage. Hepatogastroenterology. 1998;45:665-671.
23. Cesaratto L, Calligaris SD, Vascotto C, et al. Bilirubin-induced cell toxicity involves PTEN activation through an APE1/Ref-1-dependent pathway. J Mol Med (Berl). 2007;85:1099-1112.
24. Ostrow JD, Pascolo L, Brites D, Tiribelli C. Molecular basis of bilirubin-induced neurotoxicity. Trends Mol Med. 2004;10:65-70.
25. Fernandes A, Falcao AS, Silva RF, et al. Inflammatory signalling pathways involved in astroglial activation by unconjugated bilirubin. J Neurochem. 2006;96:1667-1679.
26. Fernandes A, Silva RF, Falcao AS, Brito MA, Brites D. Cytokine production, glutamate release and cell death in rat cultured astrocytes treated with unconjugated bilirubin and LPS. J Neuroimmunol. 2004;153:64-75.
27. Zhai R, Sheu CC, Su L, et al. Serum bilirubin levels on ICU admission are associated with ARDS development and mortality in sepsis. Thorax. 2009;64:784-790.
28. Leese T, Neoptolemos JP, Baker AR, Carr-Locke DL. Management of acute cholangitis and the impact of endoscopic sphincterotomy. Br J Surg. 1986;73:988-992.
29. Aronson D, Mittleman MA, Burger AJ. Elevated blood urea nitrogen level as a predictor of mortality in patients admitted for decompensated heart failure. Am J Med. 2004;116:466-473.
30. Faisst M, Wellner UF, Utzolino S, Hopt UT, Keck T. Elevated blood urea nitrogen is an independent risk factor of prolonged intensive care unit stay due to acute necrotizing pancreatitis. J Crit Care. 2010;25:105-111.
31. Thomas L. Labor und Diagnose. Germany: TH-Books-Verlagsgesellschaft, Frankfurt/Main; 2005:544-547.
32. Moore FA. Effects of immune-enhancing diets on infectious morbidity and multiple organ failure. J Parenter Enteral Nutr (JPEN). 2001;25:S36-S42; discussion S-3.
33. Doi K, Leelahavanichkul A, Hu X, et al. Pre-existing renal disease promotes sepsis-induced acute kidney injury and worsens outcome. Kidney Int. 2008;74:1017-1025.
34. Kang CI, Song JH, Chung DR, et al. Risk factors and treatment outcomes of community-onset bacteraemia caused by extended-spectrum beta-lactamase- producing Escherichia coli. Int J Antimicrob Agents. 2010;36:284-287.
35. Du B, Long Y, Liu H, et al. Extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae bloodstream infection: risk factors and clinical outcome. Intensive Care Med. 2002;28:1718-1723.
36. Lautenbach E, Metlay JP, Bilker WB, Edelstein PH, Fishman NO. Association between fluoroquinolone resistance and mortality in Escherichia coli and Klebsiella pneumoniae infections: the role of inadequate empirical antimicrobial therapy. Clin Infect Dis. 2005;41:923-929.
37. Barenfanger J, Graham DR, Kolluri L, et al. Decreased mortality associated with prompt gram staining of blood cultures. Am J Clin Pathol. 2008;130:870-876.
38. Jain S, Andrews J, Fraise A, Brenwald N. Rapid detection of extended-spectrum beta-lactamase-producing gram-negative bacilli in blood cultures. J Antimicrob Chemother. 2007;60:652-654.
39. Ercis S, Sancak B, Kocagoz T, Kocagoz S, Hascelik G, Bolmstrom A. Rapid 4 to 6 hour detection of extended-spectrum beta-lactamases in a routine laboratory. Scand J Infect Dis. 2007;39:781-785.
40. Nordmann P, Dortet L, Poirel L. Rapid detection of extended-spectrum- beta-lactamase-producing enterobacteriaceae. J Clin Microbiol. 2012;50:3016-3022.
41. Cagatay AA, Kocagoz T, Eraksoy H. Dio-sensimedia: a novel culture medium for rapid detection of extended spectrum beta-lactamases. BMC Infect Dis. 2003;3:22.
42. Colodner R, Reznik B, Gal V, Yamazaki H, Hanaki H, Kubo R. Evaluation of a novel kit for the rapid detection of extended-spectrum beta-lactamases. Eur J Clin Microbiol Infect Dis. 2006;25:49-51.
43. Boey JH, Way LW. Acute cholangitis. Ann Surg. 1980;191:264-270.
44. Hui CK, Lai KC, Yuen MF, Ng M, Lai CL, Lam SK. Acute cholangitis - predictive factors for emergency ERCP. Aliment Pharmacol Ther. 2001;15:1633-1637.